National Institutes of Health to Grant Exclusive License for In Vitro Fertilization Technology

Summary

The National Institutes of Health is considering granting an exclusive license to Amrad Corporation Limited for the use of its patented technology in in vitro fertilization, with the potential for limited clinical treatment of infertility in humans.